Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 1 | Genome Medicine

Fig. 1

From: Epigenetic timing effects on child developmental outcomes: a longitudinal meta-regression of findings from the Pregnancy And Childhood Epigenetics Consortium

Fig. 1

Mean effect sizes and statistical significance for DNAm at birth and in childhood. Mean effect sizes (left column) and mean statistical significance (right column) across all tested autosomal DNAm sites per outcome (color) and timepoint. Upper row displays results from analyses utilizing the maximum available sample sizes. Lower row displays results from analyses with cohorts removed to achieve equal sample sizes at both timepoints. Effect size is given as absolute regression coefficient (|‾β|), representing the difference in child health outcomes in SD between full or no methylation in the case of continuous outcomes (ADHD, general psychopathology, sleep duration, and BMI), or log(odds ratio) for categorical outcomes (asthma diagnosis). Statistical significance is given as mean absolute Z-values

Back to article page